Paul Fonteyne
Angel · Connecticut
Verified active in the last 12 months
Board director at 3 startups that filed Form D raises since late 2024, mostly in Connecticut.
- Stages
- Series A, Series B
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Aug 2026
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: Allyx TherapeuticsFeb 10, 2023
- SEC Form D: ApnimedNov 8, 2023
- SEC Form D: DalCor Pharmaceuticals USAug 28, 2026
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.